KVP Capital Advisors, LP
KVP Capital Advisors, LP is an SEC-registered investment adviser that reports managing 1 hedge fund on Form ADV. It reports $220.9 million in regulatory assets under management. Its private funds, of all types, hold $220.9 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +29.9% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +29.9% from Q1 2026 to Q2 2026, compared with +9.5% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $220.9 millionForm ADV Item 5.F
- Gross assets of private funds
- $220.9 millionAll private fund types, Form ADV
- Hedge funds managed
- 12 private funds in total
- Employees
- 3Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 174401
- Latest Form ADV
- 06/29/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +19.2% | +14.8% |
| Q1 2026 | +9.0% | -4.6% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Praxis Precision Medicines I$14.4 million
- Whitehawk Therapeutics Inc$9.9 million
- Erasca Inc$8.3 million
- Trevi Therapeutics Inc$7.7 million
- 869367201$7.5 million
- Tango Therapeutics Inc$7.2 million
- MBX Biosciences Inc$6.7 million
- Protagonist Therapeutics Inc$6.5 million
- Edgewise Therapeutics Inc$5.4 million
- Tandem Diabetes Care Inc$4.5 million
As of 2026-06-30, from 13F filing by KVP Capital Advisors, LP.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures